FIELD: pharmaceuticals.
SUBSTANCE: invention relates to compounds of general formula (I), general formula (II), general formula (III), general formula (IV), general formula (V), general formula (VI) and their pharmaceutically acceptable salts, where all the variables are defined in herein, which may be useful as inducers of type I interferon production, specifically as active agents of STING. Also the following is provided: a pharmaceutical composition containing such compounds and methods of using such compounds, including administering such compounds to induce an immune response, induce STING-dependent type I interferon production, and/or treat a cell proliferation disorder such as cancer.
EFFECT: obtaining sting agonists compounds.
33 cl, 26 tbl, 190 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED BENZOYLAMINOINDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS | 2008 |
|
RU2477279C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEINKINASE INHIBITORS | 2005 |
|
RU2379308C2 |
| THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS | 2013 |
|
RU2690663C2 |
| BENZIMIDAZOLE DERIVATIVES EFFECTIVE IN TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION | 2012 |
|
RU2612530C2 |
| BICYCLIC AGONISTS OF THE INTERFERON GENE STIMULATOR STING | 2020 |
|
RU2800072C1 |
| FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1 | 2014 |
|
RU2671979C2 |
| COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
